MedTrace Logo

Study of PneumRx Endobronchial Coil System in Treatment of Subjects With Severe Emphysema

NCT03360396 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2023-08-28

Study results available
· View outcomes & findings →

Summary

This study will look at outcomes between Endobronchial Coil Treatment and Control groups in patients with severe heterogeneous and or homogeneous emphysema.

Conditions

  • Emphysema

Interventions

DEVICE

Endobronchial Coils

Endobronchial Coil implants

Sponsors & Collaborators

  • PneumRx, Inc.

    collaborator INDUSTRY

  • Boston Scientific Corporation

    lead INDUSTRY

Principal Investigators

  • Felix Herth, MD, · University Hospital Heidelberg

  • Arschang Valipour, MD,FCCP,PhD · Nord-Klinik Floridsdorf

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
35 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-05-07
Primary Completion
2020-02-26
Completion
2022-11-22
FDA Device
Yes

Countries

  • Austria
  • France
  • Germany
  • Italy
  • Netherlands
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03360396 on ClinicalTrials.gov